metomotyl vet süstelahus
le vet. beheer b.v. - metoklopramiid - süstelahus - 2,23mg 1ml 30ml 1tk; 2,23mg 1ml 10ml 1tk; 2,23mg 1ml 20ml 1tk
celestoderm-v kreem
merck sharp & dohme b.v. - beetametasoon - kreem - 1mg 1g 30g 1tk; 1mg 1g 50g 1tk
ganapar süstelahus
vetpharma animal health s.l. - kloprostenool - süstelahus - 75mcg 1ml 20ml 1tk
humulin n süstesuspensioon kolbampullis
eli lilly nederland b.v. - keskmise toimeajaga humaaninsuliin - süstesuspensioon kolbampullis - 100rÜ 1ml 3ml 5tk
humulin n kwikpen süstesuspensioon pen-süstlis
eli lilly nederland b.v. - keskmise toimeajaga humaaninsuliin - süstesuspensioon pen-süstlis - 100rÜ 1ml 3ml 10tk; 100rÜ 1ml 3ml 5tk
dalmazin süstelahus
fatro s.p.a. - kloprostenool - süstelahus - 0,075mg 1ml 2ml 60tk; 0,075mg 1ml 20ml 1tk; 0,075mg 1ml 100ml 1tk; 0,075mg 1ml 2ml 15tk
betnovate ointment salv
glaxo wellcome uk limited trading as glaxo wellcome operations - beetametasoon - salv - 1mg 1g 15g 1tk
humulin r süstelahus kolbampullis
eli lilly nederland b.v. - lühikese toimeajaga humaaninsuliin - süstelahus kolbampullis - 100rÜ 1ml 3ml 5tk; 100rÜ 1ml 3ml 10tk
meriofert set süstelahuse pulber ja lahusti
ibsa farmaceutici italia s.r.l. - menopausaalne humaangonadotropiin - süstelahuse pulber ja lahusti - 900rÜ 1tk
kauliv
strides pharma (cyprus) limited - teriparatiid - osteoporosis; osteoporosis, postmenopausal - kaltsiumi homöostaas - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.